LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 4 von insgesamt 4

Suchoptionen

  1. Artikel: Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on Outcomes.

    Franchi, Eloisa / Dondossola, Daniele Eliseo / Marini, Giulia Maria Francesca / Iavarone, Massimo / Del Prete, Luca / Di Benedetto, Clara / Donato, Maria Francesca / Antonelli, Barbara / Lampertico, Pietro / Caccamo, Lucio

    Cancers

    2024  Band 16, Heft 5

    Abstract: The outcome of liver transplantation (LT) for hepatocarcinoma (HCC) is strongly influenced by HCC staging, which is based on radiological examinations in a pre-LT setting; concordance between pre-LT radiological and definitive pathological staging ... ...

    Abstract The outcome of liver transplantation (LT) for hepatocarcinoma (HCC) is strongly influenced by HCC staging, which is based on radiological examinations in a pre-LT setting; concordance between pre-LT radiological and definitive pathological staging remains controversial. To address this issue, we retrospectively analyzed our LT series to assess concordance between radiology and pathology and to explore the factors associated with poor concordance and outcomes. We included all LTs with an HCC diagnosis performed between 2013 and 2018. Concordance (Co group) was defined as a comparable tumor burden in preoperative imaging and post-transplant pathology; otherwise, non-concordance was diagnosed (nCo group). Concordance between radiology and pathology was observed in 32/134 patients (Co group, 24%). The number and diameter of the nodules were higher when nCo was diagnosed, as was the number of pre-LT treatments. Although concordance did not affect survival, more than three pre-LT treatments led to a lower disease-free survival. Patients who met the Milan Criteria (Milan-in patients) were more likely to receive ≥three prior treatments, leading to a lower survival in multi-treated Milan-in patients than in other Milan-in patients. In conclusion, the concordance rate between the pre-LT imaging and histopathological results was low in patients with a high number of nodules. Multiple bridging therapies reduce the accuracy of pre-LT imaging in predicting HCC stages and negatively affect outcomes after LT.
    Sprache Englisch
    Erscheinungsdatum 2024-03-04
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers16051043
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: A case of newly diagnosed immune thrombocytopenia in the COVID-19 era.

    Clerici, Bianca / Birocchi, Simone / Bertinato, Elena / Di Benedetto, Clara / Caberlon, Sabrina / Cattaneo, Marco / Podda, Gian Marco

    Internal and emergency medicine

    2020  Band 16, Heft 8, Seite(n) 2221–2225

    Mesh-Begriff(e) COVID-19/complications ; COVID-19/diagnostic imaging ; Humans ; Male ; Middle Aged ; Purpura, Thrombocytopenic, Idiopathic/complications ; Purpura, Thrombocytopenic, Idiopathic/diagnosis ; SARS-CoV-2/isolation & purification
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-11-12
    Erscheinungsland Italy
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-020-02553-3
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: A case of newly diagnosed immune thrombocytopenia in the COVID-19 era

    Clerici, Bianca / Birocchi, Simone / Bertinato, Elena / Di Benedetto, Clara / Caberlon, Sabrina / Cattaneo, Marco / Podda, Gian Marco

    Intern. emerg. med

    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #920059
    Datenquelle COVID19

    Kategorien

  4. Artikel ; Online: Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.

    Mehta, Gautam / Riva, Antonio / Ballester, Maria Pilar / Uson, Eva / Pujadas, Montserrat / Carvalho-Gomes, Ângela / Sahuco, Ivan / Bono, Ariadna / D'Amico, Federico / Viganò, Raffaela / Diago, Elena / Lanseros, Beatriz Tormo / Inglese, Elvira / Vazquez, Dani Martinez / Sharma, Rajni / Tsou, Hio Lam Phoebe / Harris, Nicola / Broekhoven, Annelotte / Kikkert, Marjolein /
    Morales, Shessy P Torres / Myeni, Sebenzile K / Riveiro-Barciela, Mar / Palom, Adriana / Zeni, Nicola / Brocca, Alessandra / Cussigh, Annarosa / Cmet, Sara / Escudero-García, Desamparados / Stocco, Matteo / Natola, Leonardo Antonio / Ieluzzi, Donatella / Paon, Veronica / Sangiovanni, Angelo / Farina, Elisa / di Benedetto, Clara / Sánchez-Torrijos, Yolanda / Lucena-Varela, Ana / Román, Eva / Sánchez, Elisabet / Sánchez-Aldehuelo, Rubén / López-Cardona, Julia / Canas-Perez, Itzel / Eastgate, Christine / Jeyanesan, Dhaarica / Morocho, Alejandro Esquivel / Di Cola, Simone / Lapenna, Lucia / Zaccherini, Giacomo / Bongiovanni, Deborah / Zanaga, Paola / Sayaf, Katia / Hossain, Sabir / Crespo, Javier / Robles-Díaz, Mercedes / Madejón, Antonio / Degroote, Helena / Fernández, Javier / Korenjak, Marko / Verhelst, Xavier / García-Samaniego, Javier / Andrade, Raúl J / Iruzubieta, Paula / Wright, Gavin / Caraceni, Paolo / Merli, Manuela / Patel, Vishal C / Gander, Amir / Albillos, Agustín / Soriano, Germán / Donato, Maria Francesca / Sacerdoti, David / Toniutto, Pierluigi / Buti, Maria / Duvoux, Christophe / Grossi, Paolo Antonio / Berg, Thomas / Polak, Wojciech G / Puoti, Massimo / Bosch-Comas, Anna / Belli, Luca / Burra, Patrizia / Russo, Francesco Paolo / Coenraad, Minneke / Calleja, José Luis / Perricone, Giovanni / Berenguer, Marina / Claria, Joan / Moreau, Richard / Arroyo, Vicente / Angeli, Paolo / Sánchez, Cristina / Ampuero, Javier / Piano, Salvatore / Chokshi, Shilpa / Jalan, Rajiv

    Hepatology communications

    2023  Band 7, Heft 11

    Abstract: Background: Vaccine hesitancy and lack of access remain major issues in disseminating COVID-19 vaccination to liver patients globally. Factors predicting poor response to vaccination and risk of breakthrough infection are important data to target ... ...

    Abstract Background: Vaccine hesitancy and lack of access remain major issues in disseminating COVID-19 vaccination to liver patients globally. Factors predicting poor response to vaccination and risk of breakthrough infection are important data to target booster vaccine programs. The primary aim of the current study was to measure humoral responses to 2 doses of COVID-19 vaccine. Secondary aims included the determination of factors predicting breakthrough infection.
    Methods: COVID-19 vaccination and Biomarkers in cirrhosis And post-Liver Transplantation is a prospective, multicenter, observational case-control study. Participants were recruited at 4-10 weeks following first and second vaccine doses in cirrhosis [n = 325; 94% messenger RNA (mRNA) and 6% viral vaccine], autoimmune liver disease (AILD) (n = 120; 77% mRNA and 23% viral vaccine), post-liver transplant (LT) (n = 146; 96% mRNA and 3% viral vaccine), and healthy controls (n = 51; 72% mRNA, 24% viral and 4% heterologous combination). Serological end points were measured, and data regarding breakthrough SARS-CoV-2 infection were collected.
    Results: After adjusting by age, sex, and time of sample collection, anti-Spike IgG levels were the lowest in post-LT patients compared to cirrhosis (p < 0.0001), AILD (p < 0.0001), and control (p = 0.002). Factors predicting reduced responses included older age, Child-Turcotte-Pugh B/C, and elevated IL-6 in cirrhosis; non-mRNA vaccine in AILD; and coronary artery disease, use of mycophenolate and dysregulated B-call activating factor, and lymphotoxin-α levels in LT. Incident infection occurred in 6.6%, 10.6%, 7.4%, and 15.6% of cirrhosis, AILD, post-LT, and control, respectively. The only independent factor predicting infection in cirrhosis was low albumin level.
    Conclusions: LT patients present the lowest response to the SARS-CoV-2 vaccine. In cirrhosis, the reduced response is associated with older age, stage of liver disease and systemic inflammation, and breakthrough infection with low albumin level.
    Mesh-Begriff(e) Humans ; Albumins ; Breakthrough Infections ; Case-Control Studies ; COVID-19/prevention & control ; COVID-19 Vaccines ; Liver Cirrhosis ; Liver Transplantation/adverse effects ; Prospective Studies ; RNA, Messenger ; SARS-CoV-2 ; Vaccination ; Viral Vaccines
    Chemische Substanzen Albumins ; COVID-19 Vaccines ; RNA, Messenger ; Viral Vaccines
    Sprache Englisch
    Erscheinungsdatum 2023-10-18
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
    ISSN 2471-254X
    ISSN (online) 2471-254X
    DOI 10.1097/HC9.0000000000000273
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang